S Bhaumik, TV Sekar, J Depuy, J Klimash… - Gene Therapy, 2011 - nature.com Gene-directed enzyme prodrug therapy (GDEPT) is a promising and emerging strategy that attempts to limit the systemic toxicity inherent to cancer chemotherapy by means of tumor-targeted delivery and expression of an exogenous gene whose product converts nontoxic prodrug(s) into ...
[HTML] from pnas.orgS Dhar, N Kolishetti, SJ Lippard… - Proceedings of the …, 2011 - National Acad Sciences Targeted delivery and controlled release of inactive platinum (Pt) prodrugs may offer a new approach to improve the efficacy and tolerability of the Pt family of drugs, which are used to treat 50% of all cancers today. Using prostate cancer (PCa) as a model disease, we previously ... Cited by 9 - Related articles - All 6 versions
KN Ganjoo, LD Cranmer, JE Butrynski… - Oncology, 2011 - content.karger.com Purpose: The purpose of this study was to determine the dose-limiting toxicities (DLT), maximum tolerated dose (MTD), safety, pharmacokinetics and preliminary activity of TH-302, a hypoxia-activated prodrug, in combination with doxorubicin in patients with advanced soft ... Related articles - All 2 versions
HD Thomas, LZ Wang, C Roche, J Bentley… - European Journal of …, 2011 - Elsevier To facilitate the evaluation of CDK2 (cyclin-dependent kinase 2) as a cancer target, the in vitro and in vivo properties of NU6102 (O 6 -cyclohexylmethyl-2-(4′-sulphamoylanilino)purine) and a water soluble prodrug (NU6301) were investigated. NU6102 selectively inhibited the ... Related articles - All 3 versions
S Lowe, R Dean, B Ackermann, K Jackson… - …, 2011 - Springer Abstract Rationale Accumulating evidence suggests that the primary symptoms of schizophrenia may be associated with altered central glutamate transmission. LY2140023 monohydrate is the methionine prodrug of the selective mGlu2/3 receptor agonist LY404039 and is currently ...
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
